Clinical Trials Directory

Trials / Completed

CompletedNCT06086769

High Flow Oxygen Therapy Effect on Healthy Subjects

Impact of High Flow Oxygen Therapy on Diaphragm Thickening Fraction in Healthy Subjects. A Prospective Cohort Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Argentinian Intensive Care Society · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The use of high-flow nasal cannula (HFNC) has increased. Diaphragmatic ultrasonography is a tool that, as a noninvasive complement to esophageal pressure (Pes) measurement, allows the evaluation of diaphragm function and reflects, through the diaphragm thickening fraction (DTf), the magnitude of diaphragmatic fiber recruitment. The objective of this study was to evaluate the impact of HFNC therapy on the DTf in healthy subjects. Second, this study aimed to assess the behavior of the respiratory rate (RR) and the work of breathing in these subjects.

Conditions

Interventions

TypeNameDescription
DEVICEHigh flow nasal canulaMeasurement of diaphragm thickening fraction, respiratory rate and esophageal pressure swing with calculation of diaphragmatic pressure-time product without the use of HFNC and with the use of HFNC at 20 and 40 Liters per minute

Timeline

Start date
2022-03-01
Primary completion
2022-05-30
Completion
2022-06-30
First posted
2023-10-17
Last updated
2023-10-17

Locations

1 site across 1 country: Argentina

Source: ClinicalTrials.gov record NCT06086769. Inclusion in this directory is not an endorsement.